ENDRA Life Sciences Inc. Quarterly Depreciation in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ENDRA Life Sciences Inc. quarterly/annual Depreciation history and growth rate from Q1 2016 to Q1 2024.
  • ENDRA Life Sciences Inc. Depreciation for the quarter ending March 31, 2024 was $15.3K, a 55.7% decline year-over-year.
  • ENDRA Life Sciences Inc. Depreciation for the twelve months ending March 31, 2024 was $105K, a 6.8% decline year-over-year.
  • ENDRA Life Sciences Inc. annual Depreciation for 2023 was $124K, a 28% increase from 2022.
  • ENDRA Life Sciences Inc. annual Depreciation for 2022 was $96.7K, a 16.8% decline from 2021.
  • ENDRA Life Sciences Inc. annual Depreciation for 2021 was $116K, a 17% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $105K $15.3K -$19.2K -55.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $124K $21.9K -$10.2K -31.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $134K $32.1K +$8.27K +34.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $126K $35.3K +$13.6K +62.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $112K $34.5K +$15.5K +81.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $96.7K $32.1K +$10.9K +51.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $85.8K $23.8K -$6.03K -20.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $91.8K $21.7K -$12K -35.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $104K $19K -$12.4K -39.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $116K $21.3K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $29.8K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $33.7K -$10.3K -23.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $31.4K +$9.84K +45.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q2 2020 $44K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $21.6K +$1.95K +9.95% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 $19.9K +$1.89K +10.5% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-13
Q1 2019 $19.6K +$4.29K +28% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q3 2018 $18K +$2.89K +19% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q1 2018 $61.1K $15.3K -$351 -2.24% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $61.5K $15.4K -$980 -6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-11
Q3 2017 $62.5K $15.2K -$1.17K -7.15% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $63.6K $15.3K -$817 -5.08% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $64.4K $15.7K -$491 -3.03% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $64.9K $16.3K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-20
Q3 2016 $16.3K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $16.1K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $16.2K Jan 1, 2016 Mar 31, 2016 10-Q 2017-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.